Metabolic diseases

Changes of Gut Microbiota

Animal model

Clinical research

Reference

Obesity

Increase in Prevotella, Megamonas, Fusobacterium and Blautia

Decrease in Faecalibacterium, Parabacteroides Bifidobacterium and Alistipes

yes

[42] [43]

Type 2 diabetes mellitus

Increase in Escherichia coli, some Clostridium species, Bacteroides caccae and Eggerthella lenta, Parabacteroides Enterococcus, Enterobacteriaceae, Klebsiella

Decrease in Eubacterium rectale, Clostridium SS3/4, faecalibacterium prausnitzii and Bifidobacterium intestinalis, Bacillus lactis, Prevotella, ruminococcaceae, Roseburia, faecalibacterium

yes

[16] [24]

Hypertension

Increase in Prevotella and Klebsiella Erysipelotrichacea-UCG003

Decrease in faecali, Rothia spp., oscillibacter ruminiclostridium

yes

[51] [52] [53]

Hyperlipidemia

Increase in LPS producing Escherichia coli and Enterobacter cloacae

Decrease in Bifidobacterium, Lactobacillus, faecalibacterium prausnitzii and Roseburia akkermansia, Bacteroides, Roseburia and faecalibacterium

yes

[58] [59]

Hyperuricemia

Increase in Alipipes, Dialister, Roseburia, Gemmiger, Faecalibacterium

Decrease in Bifidobacterium, Klebsiella and Clostridium

yes

[64]

Nonalcoholic fatty liver disease

Increase in Firmicutes Actinobacteria murinus Bacteroidaceae Prevotellaceae Proteobacteria Verrucomicrobia

Decrease in Actinobacteri Euryarchaeota Lachnospiraceae Ruminococcaceae Lactobacillaceae Deferribacters Bacteroidetes Lactobacillus

yes

yes

[69] [70] [71] [72]

Alcoholic fatty liver disease

Increase in Olsenella Eubacterium Acetivibrio ActinobacteriaFirmicutes Coriobacteriaceae Odoribacteriacea Clostridiaceae Dorea Candida spp. Candida albicans Candida dubliniensis Proteobacteria Fusobacteria Fusobacteriaceae Enterobacteriaceae Burkholderiaceae Escherichia-Shigella

Decrease in Proteobacteria Bacteroidetes Acinetobacter Anaerotruncus Akkermansia Blautia Epicoccum Unclassified fungi Galactomyce Debaryomyces Ruminococcaceae Faecalibacterium Lachnospira Agathobacter Ruminococcus

yes

yes

[80] [82]

Metabolic syndrome

Increase in potentially harmful bacteria

Decrease in beneficial bacteria

yes

[84]

Polycystic ovary syndrome

Increase in Prevotella Bacteroides Streptococcus Nocardiaceae and Clostridiaceae Parabacteroides, Bacteroides, Lactobacillus, Oscillibacter, Escherichia/Shigella, Clostridium

Decrease in Lactobacillus Ruminococcus Clostridium Akkermansia Ruminococcaceae Akkermansia, Bacteroides, Lactobacillus, and Clostridium Faecalibacterium, Bifidobacterium, and Blautia

yes

yes

[14] [88] [89]

Wilsons disease

Increase in Bacteroidetes, Proteobacteria, cyanobacteria and fusobacteria

Decrease in actinomycetes, Firmicutes and verrucomicrobia

yes

[92]

Osteoporosis

Increase in dialyzers and faecalibacterium, Clostridium hypervirum, faecalibacterium, Lactobacillus and egtaheira

Declease in actinomycetes, faecalibacterium, Clostridium cluster xlva and Lactobacillus, Veillonella raoullella

yes

[96] [97] [98]